L D Recht

Summary

Publications

  1. ncbi Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid
    L D Recht
    Department of Neurology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
    Biochem Pharmacol 62:755-63. 2001
  2. ncbi PTEN: a newly identified regulator of neuronal differentiation
    A H Ross
    Department of Biochemistry and Molecular Pharmacology, Worcester, MA 01655, USA
    Neuroscientist 7:278-81. 2001
  3. ncbi Neurotrophin channeling of neural progenitor cell differentiation
    B O Benoit
    Cancer Center, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA
    J Neurobiol 46:265-80. 2001

Collaborators

Detail Information

Publications3

  1. ncbi Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid
    L D Recht
    Department of Neurology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA
    Biochem Pharmacol 62:755-63. 2001
    ..Its very favorable toxicity profile, including lack of psychoactivity, makes it suitable for chronic usage. Further studies are warranted to determine its optimal role as an antitumor agent...
  2. ncbi PTEN: a newly identified regulator of neuronal differentiation
    A H Ross
    Department of Biochemistry and Molecular Pharmacology, Worcester, MA 01655, USA
    Neuroscientist 7:278-81. 2001
    ....
  3. ncbi Neurotrophin channeling of neural progenitor cell differentiation
    B O Benoit
    Cancer Center, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA
    J Neurobiol 46:265-80. 2001
    ..Removal of EGF is then permissive for the differentiating effects of BDNF and NGF. These data further indicate that the majority of EGF neurosphere clones have neurotrophin dependent tri-lineage potential...